HLP004
| Clinical data | |
|---|---|
| Other names | HLP004; HLP-004; CYB004; CYB-004; Deuterated dimethyltryptamine; Deuterated DMT; dDMT |
| Routes of administration | Inhalation, intravenous |
| Drug class | Serotonergic psychedelic; Serotonin receptor agonist |
| Pharmacokinetic data | |
| Elimination half-life | 37–40 minutes |
| Duration of action | ~40 minutes |
HLP004, or HLP-004, also known as deuterated dimethyltryptamine (dDMT) and formerly as CYB004, is a serotonergic psychedelic related to dimethyltryptamine (DMT) which is under development for the treatment of generalized anxiety disorder. It is administered by inhalation or intravenous injection. The drug is a tryptamine derivative and is a deuterated analogue and form of DMT.